Table 9 Clinical-evaluation, Kirby-Bauer AST result and empirical treatment of participants with E. coli or K. pneumoniae

20

E. coli

Yes

Yes

No

UTI

Ciprofloxacin

Ineffective*

56

E. coli

Yes

No

Yes

RTI

Ceftriaxone, cloxacillin

Effective

258

E. coli

No

Yes

Yes

AFI

None

–

259

E. coli

Yes

Yes

Yes

AFI

None

–

264

E. coli

Yes

No

No

SSTI

Ceftriaxone, metronidazole

Ineffective

272

E. coli

Yes

Yes

Yes

SSTI

Cloxacillin

Ineffective

275

E. coli

Yes

No

No

SSTI

Ceftriaxone, metronidazole

Ineffective

351

E. coli

Yes

Yes

Yes

SSTI

Ceftriaxone metronidazole

Ineffective

411

E. coli

Yes

Yes

Yes

AFI

None

–

423

E. coli

No

Yes

Yes

RTI

None

–

432

E. coli

Yes

Yes

Yes

RTI

Azithromycin, ceftriaxone

Ineffective

440

E. coli

Yes

Yes

Yes

UTI

Ceftriaxone

Ineffective

483

E. coli

Yes

Yes

No

AFI

Azithromycin, ceftriaxone

Ineffective

503

E. coli

No

No

No

RTI

None

–

568

E. coli

No

No

No

AFI

None

–

639

E. coli

Yes

No

No

UTI

None

–

42

K. pneumoniae

No

No

No

AFI

Ceftriaxone, gentamicin

Effective

59

K. pneumoniae

No

No

No

RTI

Ceftriaxone, metronidazole

Effective

64

K. pneumoniae

No

Yes

No

Meningitis / encephalitis

Ceftriaxone

Effective

278

K. pneumoniae

Yes

Yes

Yes

SSTI

Ceftriaxone, cloxacillin

Ineffective

314

K. pneumoniae

Yes

Yes

Yes

SSTI

Ceftriaxone, vancomycin

Ineffective

332

K. pneumoniae

Yes

Yes

Not

AFI, sepsis

Ceftriaxone, gentamicin

Effective

545

K. pneumoniae

Yes

Yes

Yes

UTI

Tuberculostatic treatment

Ineffective

677

K. pneumoniae

Yes

Not

No

RTI

Ceftazidime, vancomycin

Ineffective

681

K. pneumoniae

Yes

Yes

No

RTI

Ceftriaxone, vancomycin

Ineffective